Search Contract Opportunities

Anastrozole 1 MG   2

ID: SPE2D2-20-R-0065 • Type: Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: Aug. 15, 2024, 1:17 p.m. EDT

Modification P00008 SPE2D220D0101 issued to invoke option year 4 for Anastrozole National Contract.

Modification P00007 SPE2D220D0101 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.

Anastrozole 1 MG Tablets solicitation SPE2D2-20-R-0065

Posted: Aug. 17, 2023, 10:26 a.m. EDT
Posted: Aug. 3, 2023, 12:48 p.m. EDT
Posted: Aug. 18, 2022, 8:50 a.m. EDT
Posted: Sept. 1, 2021, 3:25 p.m. EDT
Posted: Sept. 1, 2021, 3:01 p.m. EDT
Posted: Sept. 17, 2020, 7:43 a.m. EDT
Posted: April 29, 2020, 9:18 a.m. EDT
Background
The Defense Logistics Agency (DLA) is issuing a solicitation for the procurement of Anastrozole 1 MG Tablets. The DLA's mission is to provide supplies and services to the military services and other federal agencies in support of national defense. The goal of this contract is to procure Anastrozole 1 MG Tablets to meet the medical needs of the military and other authorized customers.

Work Details
The solicitation is for the procurement of Anastrozole 1 MG Tablets. The tablets are required to meet the specified dosage of 1 MG. The quantity required and any specific specifications for the tablets should be detailed in this section.

Period of Performance
The Period of Performance for this contract should be specified, including the start date and end date for the delivery of Anastrozole 1 MG Tablets.

Place of Performance
The place(s) of performance for this contract should specify the geographic location(s) where the Anastrozole 1 MG Tablets are to be delivered.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
May 28, 2020, 3:00 p.m. EDT Past Due
Posted
April 29, 2020, 9:18 a.m. EDT (updated: Aug. 15, 2024, 1:17 p.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$1,000,000 - $5,000,000 (AI estimate)
On 4/29/20 DLA Troop Support - Medical issued Solicitation SPE2D2-20-R-0065 for Anastrozole 1 MG due 5/28/20. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Kyle Lewicki   Profile
Email
kyle.lewicki@dla.mil
Phone
(215) 737-3696

Documents

Posted documents for Solicitation SPE2D2-20-R-0065

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D2-20-R-0065

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D2-20-R-0065

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D2-20-R-0065

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D2-20-R-0065

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Aug. 15, 2024
Last Updated By
kyle.lewicki@dla.mil
Archive Date
Jan. 1, 2027